The most commonly used off-label drugs for breast cancer prevention are the aromatase inhibitors, anastrozole or exemestane, which can be considered for women who have contraindications for SERM use (such as having a prior deep venous thrombosis). This evidence concerns the gene CYP19A1 and breast cancer.